SEC Form 4 · accession 0001437749-17-016085
NAVIDEA BIOPHARMACEUTICALS, INC. · NAVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yehuda Michael Rice
Director
Period of report
Sep 14, 2017
Accepted (ET)
Sep 19, 2017 · 5:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000810509
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 14, 2017 | G | 28,000 | $0.00 | D | 50,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction represents shares donated as a gift to a charitable organization. This was not a market transaction and no value was received for the gifted shares.